Skip to main content

Table 2 mRNA expression of fibulin-4 in human ovarian tissues

From: Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas

 

N

Fibulin-4 mRNA

P

Control

40

0.0089 ± 0.0047

 

Benign

60

0.0092 ± 0.0054

>0.05

Pathology type

  

>0.05

Serous cystadenoma

25

0.0091 ± 0.0058

 

Mucinous cystadenoma

22

0.0098 ± 0.0067

 

Endometrioid tumor

13

0.0084 ± 0.0035

 

Carcinoma

16

0.0947 ± 0.0083

<0.05

Pathology type

0

 

>0.05

Serous cystadenocarcinoma

58

0.0872 ± 0.0097

 

Mucinous cystadenocarcinoma

56

0.0913 ± 0.0108

 

Endometrioid carcinoma

46

0.0894 ± 0.0087

 

Cell differentiation

  

<0.05

High and Medium

88

0.0257 ± 0.0084

 

Low

72

0.0968 ± 0.0113

 

Tumor stage

  

<0.05

Low stage

74

0.0284 ± 0.0075

 

High stage

86

0.0895 ± 0.0118

 

Nodal status

  

<0.05

Positive

83

0.0983 ± 0.0094

 

Negative

77

0.0309 ± 0.0081

Â